Bronchodilator reponsiveness in infants and young children with cystic fibrosis

P. Hiatt, H. Eigen, P. Yu, Robert Tepper

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Response to the inhaled bronchodilator, metaproterenol, was evaluated in 28 outpatient infants and young children with cystic fibrosis (CF) (mean age, 16 months) and in 22 normal control children (mean age, 13 months). Lung function was assessed from partial expiratory flow volume curves generated by the rapid compression techniques and was quantitated by the maximal expiratory flow at functional residual capacity (V̇maxFRC). For the normal control group there was no significant change in V̇maxFRC after the aerosol of either normal saline or metaproterenol. At baseline, the group of infants with CF had significantly lower values of V̇maxFRC than did the normal control infants (202 versus 273 ml/s, p<0.05). The CF group demonstrated no significant change from baseline V̇maxFRC after the aerosol of normal saline. However, after metaproterenol the CF group had a significant increase (p<0.001) in V̇maxFRC, which eliminated the difference in V̇maxFRC between the CF and normal control groups (267 versus 276 ml/s). We conclude that infants and young children with CF have increased bronchomotor tone and that bronchoconstriction represents a significant component of the airway obstruction present in patients with CF at this age.

Original languageEnglish
Pages (from-to)119-122
Number of pages4
JournalAmerican Review of Respiratory Disease
Volume137
Issue number1
StatePublished - 1988

Fingerprint

Bronchodilator Agents
Cystic Fibrosis
Metaproterenol
Aerosols
Functional Residual Capacity
Control Groups
Bronchoconstriction
Airway Obstruction
Reference Values
Outpatients
Lung

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Bronchodilator reponsiveness in infants and young children with cystic fibrosis. / Hiatt, P.; Eigen, H.; Yu, P.; Tepper, Robert.

In: American Review of Respiratory Disease, Vol. 137, No. 1, 1988, p. 119-122.

Research output: Contribution to journalArticle

@article{a2d26394c9ef4fb597ef8083f35ec1ef,
title = "Bronchodilator reponsiveness in infants and young children with cystic fibrosis",
abstract = "Response to the inhaled bronchodilator, metaproterenol, was evaluated in 28 outpatient infants and young children with cystic fibrosis (CF) (mean age, 16 months) and in 22 normal control children (mean age, 13 months). Lung function was assessed from partial expiratory flow volume curves generated by the rapid compression techniques and was quantitated by the maximal expiratory flow at functional residual capacity (V̇maxFRC). For the normal control group there was no significant change in V̇maxFRC after the aerosol of either normal saline or metaproterenol. At baseline, the group of infants with CF had significantly lower values of V̇maxFRC than did the normal control infants (202 versus 273 ml/s, p<0.05). The CF group demonstrated no significant change from baseline V̇maxFRC after the aerosol of normal saline. However, after metaproterenol the CF group had a significant increase (p<0.001) in V̇maxFRC, which eliminated the difference in V̇maxFRC between the CF and normal control groups (267 versus 276 ml/s). We conclude that infants and young children with CF have increased bronchomotor tone and that bronchoconstriction represents a significant component of the airway obstruction present in patients with CF at this age.",
author = "P. Hiatt and H. Eigen and P. Yu and Robert Tepper",
year = "1988",
language = "English",
volume = "137",
pages = "119--122",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "1",

}

TY - JOUR

T1 - Bronchodilator reponsiveness in infants and young children with cystic fibrosis

AU - Hiatt, P.

AU - Eigen, H.

AU - Yu, P.

AU - Tepper, Robert

PY - 1988

Y1 - 1988

N2 - Response to the inhaled bronchodilator, metaproterenol, was evaluated in 28 outpatient infants and young children with cystic fibrosis (CF) (mean age, 16 months) and in 22 normal control children (mean age, 13 months). Lung function was assessed from partial expiratory flow volume curves generated by the rapid compression techniques and was quantitated by the maximal expiratory flow at functional residual capacity (V̇maxFRC). For the normal control group there was no significant change in V̇maxFRC after the aerosol of either normal saline or metaproterenol. At baseline, the group of infants with CF had significantly lower values of V̇maxFRC than did the normal control infants (202 versus 273 ml/s, p<0.05). The CF group demonstrated no significant change from baseline V̇maxFRC after the aerosol of normal saline. However, after metaproterenol the CF group had a significant increase (p<0.001) in V̇maxFRC, which eliminated the difference in V̇maxFRC between the CF and normal control groups (267 versus 276 ml/s). We conclude that infants and young children with CF have increased bronchomotor tone and that bronchoconstriction represents a significant component of the airway obstruction present in patients with CF at this age.

AB - Response to the inhaled bronchodilator, metaproterenol, was evaluated in 28 outpatient infants and young children with cystic fibrosis (CF) (mean age, 16 months) and in 22 normal control children (mean age, 13 months). Lung function was assessed from partial expiratory flow volume curves generated by the rapid compression techniques and was quantitated by the maximal expiratory flow at functional residual capacity (V̇maxFRC). For the normal control group there was no significant change in V̇maxFRC after the aerosol of either normal saline or metaproterenol. At baseline, the group of infants with CF had significantly lower values of V̇maxFRC than did the normal control infants (202 versus 273 ml/s, p<0.05). The CF group demonstrated no significant change from baseline V̇maxFRC after the aerosol of normal saline. However, after metaproterenol the CF group had a significant increase (p<0.001) in V̇maxFRC, which eliminated the difference in V̇maxFRC between the CF and normal control groups (267 versus 276 ml/s). We conclude that infants and young children with CF have increased bronchomotor tone and that bronchoconstriction represents a significant component of the airway obstruction present in patients with CF at this age.

UR - http://www.scopus.com/inward/record.url?scp=0023819109&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023819109&partnerID=8YFLogxK

M3 - Article

C2 - 3337451

AN - SCOPUS:0023819109

VL - 137

SP - 119

EP - 122

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 1

ER -